Loading chat...
KS HB2684
Bill
Status
Introduced
2/4/2026
Primary Sponsor
Insurance
Click for details
AI Summary
- Requires all individual and group health insurance plans in Kansas delivered, issued, amended, or renewed on or after January 1, 2027 to cover prescription insulin drugs and diabetes management devices with out-of-pocket cost caps
- Limits a covered person's cost to no more than $35 per 30-day supply for all prescription insulin drugs and no more than $100 per 30-day supply for diabetes devices (glucose monitors, test strips, lancets, syringes — excluding insulin pumps)
- Mandates that health plans cover at least one insulin drug in each of eight categories (rapid acting, ultra rapid acting, short acting, intermediate acting, long acting, pre-mixed insulin, pre-mixed insulin/GLP-1 RA, and concentrated human regular insulin) as well as diabetes self-management education from appropriately trained providers
- Prohibits contracts between insurers and pharmacy benefits managers from including provisions that exceed the cost-sharing caps, and bars PBMs or insurers from reducing pharmacy reimbursement rates or imposing fees/charge-backs on pharmacies as a result of the lowered patient cost-sharing
- Requires insurers to provide a written appeals process for covered persons unable to take one or more of the covered insulin drugs, and directs the Commissioner of Insurance and Board of Healing Arts to adopt implementing rules and regulations
Legislative Description
Providing price limits and other requirements for health benefits covering prescription insulin drugs and establishing the insulin affordability program for the uninsured.
Last Action
House Referred to Committee on Insurance
2/4/2026
Committee Referrals
Insurance2/4/2026
Full Bill Text
No bill text available